The latest update is out from AdAlta Ltd. ( (AU:1AD) ).
AdAlta Limited has issued 11,111,111 fully paid ordinary shares as part of its funding arrangements with NLSC, LLC. This share issuance, priced at $0.009 per share, is intended to partially settle an outstanding subscription amount, reflecting the company’s ongoing efforts to manage its financial commitments and support its operational growth.
More about AdAlta Ltd.
AdAlta Limited operates in the biotechnology industry, focusing on developing novel therapeutic products. The company is known for its innovative approach to drug discovery and development, particularly in the area of protein-based therapies.
YTD Price Performance: -37.50%
Average Trading Volume: 409,678
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$6.32M
For an in-depth examination of 1AD stock, go to TipRanks’ Stock Analysis page.